General Information of the Compound
Compound ID |
CP0429999
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
[[(2R,3aR,4R,6R,6aR)-4-(6-aminopurin-9-yl)-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate;azane
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C17H32N9O13P3
|
||||||||||||||||||
Molecular Weight |
663.415
|
||||||||||||||||||
Canonical SMILES |
N.N.N.N.Nc1ncnc2n(cnc12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@H]2O[C@H](O[C@@H]12)c1ccccc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C17H20N5O13P3.4H3N/c18-14-11-15(20-7-19-14)22(8-21-11)16-13-12(32-17(33-13)9-4-2-1-3-5-9)10(31-16)6-30-37(26,27)35-38(28,29)34-36(23,24)25;;;;/h1-5,7-8,10,12-13,16-17H,6H2,(H,26,27)(H,28,29)(H2,18,19,20)(H2,23,24,25);4*1H3/t10-,12-,13-,16-,17-;;;;/m1..../s1
Show/Hide
|
||||||||||||||||||
InChIKey |
BCGDNNLMSKVHGV-ZQNBMKNCSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04758, P2X purinoceptor 1
Protein ID: PT04148, P2X purinoceptor 2
Protein ID: PT03393, P2X purinoceptor 3
Protein ID: PT02908, P2X purinoceptor 4
Protein ID: PT01449, P2X purinoceptor 7